Every day, people in Maryland and across the country rely on medical products to be effective and clean. When medical products are contaminated with dangerous bacteria, these defective products can cause serious illness and death. The U.S. Food and Drug Administration is the government agency tasked with protecting the public from dangerous drugs and medical products and the agency has the authority to seize tainted or dangerous products in order to safeguard the public health.
Medical device manufacturers are held to a high standard. The products they produce are expected to work properly. When their products are defective or fail, the results can be catastrophic to patients.
We initially reported on allegations of medical stents being improperly placed into potentially hundreds of patients at St. Joseph Medical Center in Towson in August, when the matter first began to assume media prominence.
The saga involving Dr. Mark G. Midei continues, and we update readers here to keep them abreast of matters in this medical malpractice story that features an increasing amount of litigation surrounding allegations that stents were implanted into many hundreds of heart patients at the St. Joseph Medical Center in Towson.
In a blog post from August, we reported on a medical malpractice case that has prominently resurfaced in the news, as developments in the matter continue to go forward on several fronts. We update the story here.
Members of Maryland's Board of Physicians met with Dr. Mark G. Midei in a closed-door "case resolution conference" August 4 in Baltimore to address allegations that he placed stents unnecessarily into potentially many hundreds of patients during the period he supervised the St. Joseph Medical Center cardiac catheterization lab in Towson. The hospital revoked his hospital privileges last year.